Newsroom | 43469 results

SHANGHAI--(BUSINESS WIRE)--YolTech Therapeutics, a late clinical-stage biotechnology company developing in vivo gene-editing therapies, today announced that the U.S. Food and Drug Administration (FDA) has approved the Investigational New Drug (IND) application for YOLT-202, the company’s investigational in vivo base-editing therapy for the treatment of Alpha-1 Antitrypsin Deficiency (AATD). The FDA approval enables the initiation of an open-label, single-dose expansion Phase 2/3 clinical study...

DANBURY, Conn.--(BUSINESS WIRE)--Fertility care that feels personal, empowering, and rooted in trust has arrived in Danbury. The Center for Advanced Reproductive Services (CARS), a nationally respected fertility center affiliated with the UConn School of Medicine, has opened its newest location at 73 Sand Pit Road—making exceptional fertility care more accessible to families in western Connecticut. At the heart of the new office is Dr. Maya Barsky (MD, MSCI), a board-certified reproductive endo...

PHOENIX--(BUSINESS WIRE)--Western Alliance Bank (NYSE: WAL) today announced the launch of its specialized Healthcare commercial banking team, led by industry executive Jennifer Hwang. Hwang will build and lead a Healthcare banking team that will deliver strategic, integrated financial advice and solutions to clients across subsectors including specialty pharmaceuticals, home health and hospice, medical device, ambulatory surgical centers and providers. Healthcare is the latest addition to Weste...

PALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the results of a new national survey conducted on its behalf by The Harris Poll with findings demonstrating that more than 9 out of 10 Americans ages 45 and over believe in ensuring broader coverage for blood-based colorectal cancer (CRC) screening, including new innovations like Shield™ by Guardant, a methylation partitioning cell-free DNA (mp-cfDNA) test and the first...

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Alto Neuroscience, Inc. (“Alto”) (NYSE: ANRO) a clinical-stage biopharmaceutical company focused on the development of novel precision medicines for neuropsychiatric disorders, today announced that members of the Company’s management team will participate in a virtual fireside chat at the Stifel 2026 Virtual CNS Forum on March 17, 2026 at 12:00pm ET. The presentation will be accessible via a live webcast on the Events and Presentations page in the Investo...

ARLINGTON, Texas--(BUSINESS WIRE)--AOM Infusion (“AOM”), a leading specialty infusion pharmacy and provider, today announced it has joined Kedrion Biopharma’s limited distribution network for QIVIGY®, a new 10% immune globulin (Ig) liquid indicated for treatment of adults with Primary Humoral Immunodeficiency (PI). The addition of QIVIGY expands AOM’s immune globulin portfolio and strengthens its ability to help patients and providers access innovative therapies for complex immune disorders. Th...

BELO HORIZONTE, Brazil--(BUSINESS WIRE)--Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or the “Company”), the leading medical education group and medical practice solutions provider in Brazil, reported today its financial and operating results for the fourth quarter and full-year period ended December 31, 2025. Financial results are expressed in Brazilian Reais and are presented in accordance with International Financial Reporting Standards (IFRS). Fourth Quarter 2025 Highlights 4Q25 Revenue...

CHICAGO--(BUSINESS WIRE)--AIDS Healthcare Foundation (AHF) and its Chicago area affiliate organizations the South Side Help Center (SSHC) and CALOR will team to host a street protest and give testimony before the Chicago Department of Health’s HIV Planning Committee at an emergency public meeting on Friday, March 13, to oppose and halt planned grant funding cuts. The organizations’ actions are part of an effort to restore funding of AHF's HIV Primary Care Services and SSHC's Early Intervention...

CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--Aptar Pharma and COVIRIX Medical collaborate to assess feasibility of adapting Aptar Pharma’s proprietary DPI platform for antiviral delivery....

BLOOMINGTON, Minn.--(BUSINESS WIRE)--A commentary from HealthPartners Institute published in the Journal of Aging Research & Lifestyle points to a hidden cost of modern work. As jobs increasingly revolve around screens, long hours of sitting and constant connectivity, the brain systems that power memory, focus, creativity and emotional well-being are under strain. The commentary, written by Nico Pronk, PhD, president and chief science officer of HealthPartners Institute, describes a “sedent...